skip to content

EPSRC IRC in Targeted Delivery for Hard-to-Treat Cancers

Schematic showing formation of the hydrogel

We are developing injectable, self-healing and mechanically tuneable hydrogels. They are designed to match the mechanical properties of the contiguous human tissue and through molecular design we will engineer the architecture to either enable slow release to prevent tumour recurrence or to rapidly deliver the therapeutic compound where that is required.